WaveMan · Form 4
Lynx1 Capital Management LP insider trades
> Search tickers & screens ⌘K
LIVE

Lynx1 Capital Management LP insider trades

Lynx1 Capital Management LP has filed 11 Form 4s with the SEC that we hold, for TScan Therapeutics, Inc. (TCRX) (10% owner), Passage BIO, Inc. (PASG) (10% owner), Cullinan Therapeutics, Inc. (CGEM) (10% owner) and Korro Bio, Inc. (KRRO) (10% owner), among 5 companies in all. Across all of them we count 22 purchases worth $19.8M and 3 sales worth $63.9K reported on Form 4. In the last 12 months: 10 purchases ($5.6M) and 0 sales ($0). The largest single trade was a purchase of 626,043 shares of Cullinan Therapeutics, Inc. worth $4.2M, dated 2025-10-09. The first filing on our record is dated 2023-06-02 and the latest 2026-08-13.

TScan Therapeutics, Inc. (TCRX)

10% owner · 4 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-05-31S, sale reported on Form 4400$1.0K2023-06-02
2023-05-31S, sale reported on Form 410,000$25.1K2023-06-02
2023-05-31S, sale reported on Form 415,000$37.8K2023-06-02
2025-05-19P, purchase reported on Form 41,388,794$1.7M2025-05-21
2025-05-20P, purchase reported on Form 41,200,000$1.4M2025-05-21
2025-12-19P, purchase reported on Form 480,069$72.1K2025-12-23
2025-12-22P, purchase reported on Form 475,500$68.0K2025-12-23
2025-12-23P, purchase reported on Form 46,232$5.6K2025-12-23

Passage BIO, Inc. (PASG)

10% owner · 3 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-11-25P, purchase reported on Form 4259,998$145.6K2024-11-27
2024-11-26P, purchase reported on Form 4167,055$118.6K2024-11-27
2024-11-27P, purchase reported on Form 429,300$19.6K2024-11-27
2024-12-27P, purchase reported on Form 4373,645$242.9K2024-12-31
2025-07-22P, purchase reported on Form 413,123$71.4K2025-07-24
2025-07-23P, purchase reported on Form 449,302$283.0K2025-07-24
2025-07-24P, purchase reported on Form 466,423$379.3K2025-07-24

Cullinan Therapeutics, Inc. (CGEM)

10% owner · 2 filings · 7 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-08P, purchase reported on Form 4556,300$3.6M2025-10-10
2025-10-09P, purchase reported on Form 4626,043$4.2M2025-10-10
2025-10-10P, purchase reported on Form 4277,298$2.0M2025-10-10
2025-10-14P, purchase reported on Form 415,032$114.1K2025-10-21
2025-10-15P, purchase reported on Form 451,500$408.9K2025-10-21
2025-10-16P, purchase reported on Form 4150,000$1.3M2025-10-21
2025-10-17P, purchase reported on Form 432,217$252.6K2025-10-21

Korro Bio, Inc. (KRRO)

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-08-06P, purchase reported on Form 45,222$59.5K2026-08-13
2026-08-10P, purchase reported on Form 41,462$19.3K2026-08-13

Neuphoria Therapeutics Inc. (NEUP)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2025-10-21P, purchase reported on Form 4639,110$3.3M2025-10-23
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1910456) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms